Express Pharma

US FDA approves ABRYSVO, Pfizer’s maternal RSV vaccine for infants

First and only US approval of a maternal vaccine to help protect infants at birth through six months of life from lower respiratory tract disease (LRTD) and severe LRTD due to RSV

0 297